← Back to Search

Slow-paced walking for Coronary Artery Disease

N/A
Waitlist Available
Led By Demetra Christou, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 15 minutes after exercise and 1 hour after exercise
Awards & highlights

Study Summary

This trial looks at how exercise affects blood flow in women with coronary artery disease.

Eligible Conditions
  • Non Obstructive Coronary Artery Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 15 minutes after exercise and 1 hour after exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 15 minutes after exercise and 1 hour after exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in endothelium-dependent dilation
Secondary outcome measures
Change in arterial stiffness and wave reflection
Change in endothelium-independent dilation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Slow-paced walkingExperimental Treatment1 Intervention
Subjects will complete 47 minutes of walking at slow pace.

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,689 Total Patients Enrolled
44 Trials studying Coronary Artery Disease
30,143 Patients Enrolled for Coronary Artery Disease
Demetra Christou, PhDPrincipal InvestigatorUniversity of Florida
7 Previous Clinical Trials
442 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age range for patients in this trial inclusive of those over fifty years old?

"The study's eligibility criteria prescribes a minimum age of 18 and an upper limit set at 89 years."

Answered by AI

Is this research undertaking presently enrolling participants?

"Affirmative. Clinicaltrials.gov data confirms that since its initial posting on June 1st 2015, this medical trial is still actively recruiting for 75 patients from one centre."

Answered by AI

Who would be considered an eligible participant of this clinical trial?

"This medical research is enrolling 75 individuals aged 18 to 89 with minoca. To qualify, patients must satisfy the age requirement of being between 18 and 89 years old."

Answered by AI

How many participants can take part in this examination?

"Affirmative. The clinicaltrials.gov website confirms that this medical trial is actively recruiting participants, having first been posted on June 1st 2015 and last updated on June 29th 2022. At present, the study requires 75 individuals to be recruited at one site."

Answered by AI
~1 spots leftby Apr 2025